Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β. This growth factor may derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extracellular matrix proteins By dermal fibroblasts. Anti-Fibrotic Drug as treatment of cutaneous fibrosis that stops the action of TGF-β, reducing the amount of fibrosis.
This report contains market size and forecasts of Antifibrotic Drugs in global, including the following market information:
Global Antifibrotic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antifibrotic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antifibrotic Drugs companies in 2021 (%)
The global Antifibrotic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antifibrotic Drugs include Pfizer, Novartis, Sanofi, Merck, Roche, Bayer, Boehringer Ingelheim and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antifibrotic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antifibrotic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antifibrotic Drugs Market Segment Percentages, by Type, 2021 (%)
Oral
Injectable
Topical
Global Antifibrotic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antifibrotic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Global Antifibrotic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antifibrotic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antifibrotic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antifibrotic Drugs revenues share in global market, 2021 (%)
Key companies Antifibrotic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antifibrotic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Sanofi
Merck
Roche
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb